Pharmafile Logo
Pharmafocus logo
Advanced Search

blood clots

Showing 4 posts of 4 posts found.

bhf

British Heart Foundation funding trial of experimental drug designed to prevent blood clots in coronavirus patients

June 16, 2020
Manufacturing and Production COVID-19, blood clots, coronavirus

The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015
Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …

News

Negative overtures persuade Sanofi to withdraw drug filing

July 10, 2012
Sales and Marketing EMA, Mulsevo, Sanofi, blood clots, withdrawal

Sanofi has withdrawn its marketing applications worldwide for its drug Mulsevo. Designed to stop blood clots in cancer patients receiving …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024